Replies to post #313368 on Amarin Corp Plc (AMRN)

[rosemountbomber]

I was thinking about this and really hope that the FDA would do something and that it wouldn’t come to this idea of Amarin bringing this directly to patients because I can’t think of any examples where a brand company did DTC bashing generic versions of their drug.

If anyone can think of instances where this has happened it would be good to know. Heck in our system I am even wondering if the FDA/FTC would even permit commercials by Amarin going after the Generics’ product.